Viewing Study NCT05886634

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:29 AM
Ignite Modification Date: 2026-01-08 @ 2:34 AM
Study NCT ID: NCT05886634
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-20
First Post: 2023-05-23
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Dedifferentiated Liposarcoma View
None Soft Tissue Sarcoma View
None Sarcoma,Soft Tissue View
None Sarcoma View
None Recurrent Dedifferentiated Liposarcoma View
None Unresectable Dedifferentiated Liposarcoma View
None Metastatic Dedifferentiated Liposarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Dedifferentiated Liposarcoma View
None Recurrent Dedifferentiated Liposarcoma View
None Unresectable Dedifferentiated Liposarcoma View
None Metastatic Dedifferentiated Liposarcoma View
None Soft Tissue Sarcoma View
None Sarcoma, Soft Tissue View
None Sarcoma View
None DDLPS View
None Memorial Sloan Kettering Cancer Center View
None 22-277 View